A human nk/t cell line
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- INST OF GENETICS & DEVELOPMENTAL BIOLOGY CHINESE ACAD OF SCI
- Publication Date
- 2020-11-06
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to cell lines, in particular to a human NK / T cell line. Background technique
[0002] T cells can be divided into two subgroups according to whether they express CD4 or CD8 receptor molecules. CD8+ T cells are mainly responsible for the elimination of target cells through direct killing, such as cells infected by viruses and cells expressing tumor-specific antigens. Natural killer cells (NK cells) are important immune cells in the body, which have anti-tumor, anti-viral infection and immune regulation functions.
[0003] NK cells and T cells have long been considered excellent weapons for killing cancer cells and treating infections. Adoptive immunotherapy typically involves harvesting T cells from cancer patients, arming them with tumor-specific receptors in the laboratory, and reinfusing them back into the patient. However, adoptive immunotherapy is time-consuming, and cancer patients may not have enough T cells or NK...